Guillaume Lang

Polo-like kinase 1: a potential therapeutic option in combination with conventional chemotherapy for the management of patients with triple-negative breast cancer.

Emmanuel Barillot, Anne Vincent-Salomon, Guillem Rigaill, 2013, Cancer research.